Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1529564, 9 pages
https://doi.org/10.1155/2017/1529564
Research Article

CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention

1Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China
2Lung Cancer Diagnosis and Treatment Center, Dalian, Liaoning 116011, China
3Department of Thoracic Surgery, Xingtai People’s Hospital, Xingtai, Hebei 054031, China
4China National Research Institute of Food & Fermentation Industries, Beijing 100015, China

Correspondence should be addressed to Jinxiu Li; nc.ude.umd@uixnijil and Chundong Gu; nc.ude.umd@gnodnuhcug

Received 31 December 2016; Accepted 22 January 2017; Published 9 March 2017

Academic Editor: Alexander N. Orekhov

Copyright © 2017 Fengzhou Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Fengzhou Li, Shaofeng Zhang, Qi Zhang, Jinxiu Li, Shilei Zhao, and Chundong Gu, “CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention,” BioMed Research International, vol. 2017, Article ID 1529564, 9 pages, 2017. https://doi.org/10.1155/2017/1529564.